92 related articles for article (PubMed ID: 12164431)
1. Impaired fasting glucose versus impaired glucose tolerance.
Rajendran B
J Assoc Physicians India; 2002 Apr; 50():614; author reply 614-5. PubMed ID: 12164431
[No Abstract] [Full Text] [Related]
2. Comparison of The World Health Organization (WHO) two-step strategy and OGTT for diabetes mellitus screening.
Adam JM; Tarigan NP
Acta Med Indones; 2004; 36(1):3-7. PubMed ID: 15931695
[TBL] [Abstract][Full Text] [Related]
3. Impaired glucose tolerance and impaired fasting glucose.
Rao SS; Disraeli P; McGregor T
Am Fam Physician; 2004 Apr; 69(8):1961-8. PubMed ID: 15117017
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of impaired fasting glycemia, impaired glucose tolerance, and type 2 diabetes in hemodialyzed patients when applying new diagnostic criteria.
Elbert A; Schreier L; Galli C; Beresan H; Lopez G; Traversa M; Berg G
J Ren Nutr; 2006 Oct; 16(4):300-3. PubMed ID: 17046613
[TBL] [Abstract][Full Text] [Related]
5. Point-of-care testing as a tool for screening for diabetes and pre-diabetes.
Rush E; Crook N; Simmons D
Diabet Med; 2008 Sep; 25(9):1070-5. PubMed ID: 19183312
[TBL] [Abstract][Full Text] [Related]
6. A step backward--or is it forward?
Genuth S; Kahn R
Diabetes Care; 2008 Jun; 31(6):1093-6. PubMed ID: 18509143
[No Abstract] [Full Text] [Related]
7. Making things easier is not so easy. The 1997 American Diabetes Association criteria and glucose intolerance.
Aguilar-Salinas CA; García-García E; Lerman-Garber I; Gómez-Pérez FJ; Rull JA
Diabetes Care; 1998 Jun; 21(6):1027-8. PubMed ID: 9614628
[No Abstract] [Full Text] [Related]
8. High prevalence of neuropathy in patients with impaired 60-minute oral glucose tolerance test but normal fasting and 120-minute glucose levels.
Sahin M; Karatas M; Sahin M; Ertugrul D; Kulaksizoğlu M; Dogruk A; Gokcel A; Tutuncu NB; Guvener ND; Kutlu M
Minerva Endocrinol; 2008 Dec; 33(4):289-96. PubMed ID: 18923366
[TBL] [Abstract][Full Text] [Related]
9. Gestational diabetes: implications of variation in post-partum follow-up criteria.
Agarwal MM; Punnose J; Dhatt GS
Eur J Obstet Gynecol Reprod Biol; 2004 Apr; 113(2):149-53. PubMed ID: 15063951
[TBL] [Abstract][Full Text] [Related]
10. Glucose and cardiovascular risk.
Fuchs M; Hoekstra JB; Mudde AH
Neth J Med; 2002 Jun; 60(5):192-9. PubMed ID: 12365474
[TBL] [Abstract][Full Text] [Related]
11. [Comparison of ADA and WHO diagnostic criteria for diabetes diagnosis and other categories of glucose intolerance ].
Herdzik E; Safranow K; Ciechanowski K; Byra E; Gołdyn U
Pol Merkur Lekarski; 2002 Oct; 13(76):316-20. PubMed ID: 12557440
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of new and known diabetes mellitus, impaired glucose tolerance, and impaired fasting glucose.
Florkowski CM; Beaven DW
N Z Med J; 2007 Aug; 120(1259):U2674. PubMed ID: 17721578
[No Abstract] [Full Text] [Related]
13. [Effect of impaired fasting glucose and impaired glucose tolerance on the progression of diabetic macroangiopathy].
Igarashi M; Tominaga M
Nihon Rinsho; 2005 Feb; 63 Suppl 2():55-60. PubMed ID: 15779345
[No Abstract] [Full Text] [Related]
14. Diagnosis of diabetes. First define impaired fasting glycaemia.
Sulaiman R; Labib M
BMJ; 2009 Dec; 339():b5642. PubMed ID: 20044397
[No Abstract] [Full Text] [Related]
15. Diabetes or impaired glucose tolerance: does the label matter?
Lara C; Ponce de Leon S; Foncerrada H; Vega M
Diabetes Care; 2007 Dec; 30(12):3029-30. PubMed ID: 17728483
[No Abstract] [Full Text] [Related]
16. All pre-diabetes is not the same: metabolic and vascular risks of impaired fasting glucose at 100 versus 110 mg/dl: the Screening for Impaired Glucose Tolerance study 1 (SIGT 1).
Phillips LS; Weintraub WS; Ziemer DC; Kolm P; Foster JK; Vaccarino V; Rhee MK; Budhwani RK; Caudle JM
Diabetes Care; 2006 Jun; 29(6):1405-7. PubMed ID: 16732034
[No Abstract] [Full Text] [Related]
17. Impaired fasting glucose and impaired glucose tolerance: implications for care.
Nathan DM; Davidson MB; DeFronzo RA; Heine RJ; Henry RR; Pratley R; Zinman B;
Diabetes Care; 2007 Mar; 30(3):753-9. PubMed ID: 17327355
[No Abstract] [Full Text] [Related]
18. Use of glucose, insulin, and C-reactive protein to determine need for glucose tolerance testing.
Thompson WG; Bergstralh EJ; Slezak JM
Obes Res; 2003 Aug; 11(8):1027-32. PubMed ID: 12917509
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of diabetes mellitus and impaired glucose tolerance in a rural Palestinian population.
Husseini A; Abdul-Rahim H; Awartani F; Jervell J; Bjertness E
East Mediterr Health J; 2000; 6(5-6):1039-45. PubMed ID: 12197326
[TBL] [Abstract][Full Text] [Related]
20. Risk of cardiovascular and all-cause mortality in individuals with diabetes mellitus, impaired fasting glucose, and impaired glucose tolerance: the Australian Diabetes, Obesity, and Lifestyle Study (AusDiab).
Barr EL; Zimmet PZ; Welborn TA; Jolley D; Magliano DJ; Dunstan DW; Cameron AJ; Dwyer T; Taylor HR; Tonkin AM; Wong TY; McNeil J; Shaw JE
Circulation; 2007 Jul; 116(2):151-7. PubMed ID: 17576864
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
